Yasons Chemex Care Limited

As of March 31, 2023, Yasons Chemex Care Limited has 19.30M shares outstanding.

As of March 31, 2023, Yasons Chemex Care Limited maintains a current ratio of 3.33, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 16.72, indicating elevated leverage, while an interest coverage ratio of 1.39 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2023, Yasons Chemex Care Limited posted a return on equity (ROE) of 18.06, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 1.43 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 12.39, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 16.81, useful for judging operating efficiency across full business cycles. The company generates approximately 45.97M in revenue per employee across its workforce of 8.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.84 indicates how many times Yasons Chemex Care Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2023, Yasons Chemex Care Limited recorded 7.86M in income tax expense. That works out to an effective tax rate of 18.64, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 42.18M, leaving 34.32M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 21, 2026, Yasons Chemex Care Limited's stock has declined approximately 39.23% over the past 52 weeks. The 50-day moving average sits at 9.26, while the 200-day moving average is 11.00.

Over the twelve months ended March 31, 2023, Yasons Chemex Care Limited generated 367.73M in revenue and converted that into 34.32M in net income, yielding earnings per share of 2.42. EBITDA reached 4.96M, while operating income came in at 3.95M.

As of March 31, 2023, Yasons Chemex Care Limited holds 844,000.00 in cash and equivalents against 34.64M in total debt, resulting in a net debt position of 33.80M. Total book value stands at 207.20M, with working capital of 141.63M providing operational flexibility.

Yasons Chemex Care Limited produced -2.69M in operating cash flow over the twelve months ended March 31, 2023. After subtracting -14,000.00 in capital expenditures, free cash flow totaled -2.70M - equivalent to -0.19 per share.

Over the twelve months ended March 31, 2023, Yasons Chemex Care Limited posted a gross margin of 3.43, reflecting its pricing power and cost economics. The operating margin of 1.07 and net profit margin of 9.33 provide insight into operational efficiency.